EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Single-cell transcriptomic analyses provide insights into the cellular origins and drivers of brain metastasis from lung adenocarcinoma

Zihao Wang, Yaning Wang iD, Mengqi Chang, Yuekun Wang, Peng Liu, Jianqiang Wu, Guige Wang, Xiaoyue Tang, Xiangyi Hui, Penghao Liu, Xiaopeng Guo iD, Bing Xing iD und 3 weitere

Neuro-Oncology · 06.07.2023 · 25 (7) · 1262-1274

DOI: 10.1093/neuonc/noad017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, online erschienen am 19.01.2023. Verfasst von Zihao Wang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Chi…. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms, Brain Neoplasms. Die Arbeit wurde bisher 83-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, CAMS Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Brain metastasis (BM) is the most common intracranial malignancy causing significant mortality, and lung cancer is the most common origin of BM. However, the cellular origins and drivers of BM from lung adenocarcinoma (LUAD) have yet to be defined.

Methods

The cellular constitutions were characterized by single-cell transcriptomic profiles of 11 LUAD primary tumor (PT) and 10 BM samples (GSE131907). Copy number variation (CNV) and clonality analysis were applied to illustrate the cellular origins of BM tumors. Brain metastasis-associated epithelial cells (BMAECs) were identified by pseudotime trajectory analysis. By using machine-learning algorithms, we developed the BM-index representing the relative abundance of BMAECs in the bulk RNA-seq data indicating a high risk of BM. Therapeutic drugs targeting BMAECs were predicted based on the drug sensitivity data of cancer cell lines.

Results

Differences in macrophages and T cells between PTs and BMs were investigated by single-cell RNA (scRNA) and immunohistochemistry and immunofluorescence data. CNV analysis demonstrated BM was derived from subclones of PT with a gain of chromosome 7. We then identified BMAECs and their biomarker, S100A9. Immunofluorescence indicated strong correlations of BMAECs with metastasis and prognosis evaluated by the paired PT and BM samples from Peking Union Medical College Hospital. We further evaluated the clinical significance of the BM-index and identified 7 drugs that potentially target BMAECs.

Conclusions

This study clarified possible cellular origins and drivers of metastatic LUAD at the single-cell level and laid a foundation for early detection of LUAD patients with a high risk of BM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungLung NeoplasmsBrain NeoplasmsHumansDNA Copy Number VariationsTranscriptome

Stichwörter der Autor:innen

Brain metastasisS100A9immune microenvironmentlung adenocarcinomascRNA-seq

Autor:innen und Institutionen

  • Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Breast Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Medical Research Center, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

ORCID-Profile: Yaning Wang, Xiaopeng Guo, Bing Xing

Förderung

  • National Natural Science Foundation of China
  • CAMS Innovation Fund for Medical Sciences

Zitieren

APA

Wang, Z., Wang, Y., Chang, M., Wang, Y., Liu, P., Wu, J., Wang, G., Tang, X., Hui, X., Liu, P., Guo, X., Xing, B., Wang, Y., Han, Z., & Ma, W. (2023). Single-cell transcriptomic analyses provide insights into the cellular origins and drivers of brain metastasis from lung adenocarcinoma. Neuro-Oncology, 25(7), 1262-1274. https://doi.org/10.1093/neuonc/noad017

Vancouver

Wang Z, Wang Y, Chang M, Wang Y, Liu P, Wu J, et al. Single-cell transcriptomic analyses provide insights into the cellular origins and drivers of brain metastasis from lung adenocarcinoma. Neuro-Oncology. 2023;25(7):1262-1274. doi:10.1093/neuonc/noad017

BibTeX
@article{Wang2023,
  author = {Wang, Zihao and Wang, Yaning and Chang, Mengqi and Wang, Yuekun and Liu, Peng and Wu, Jianqiang and Wang, Guige and Tang, Xiaoyue and Hui, Xiangyi and Liu, Penghao and Guo, Xiaopeng and Xing, Bing and Wang, Yu and Han, Zhijun and Ma, Wenbin},
  title = {Single-cell transcriptomic analyses provide insights into the cellular origins and drivers of brain metastasis from lung adenocarcinoma},
  journal = {Neuro-Oncology},
  year = {2023},
  volume = {25},
  number = {7},
  pages = {1262--1274},
  doi = {10.1093/neuonc/noad017}
}
Kostenlos starten →